GeneOne Life Science, Inc. (KRX:011000)
South Korea · Delayed Price · Currency is KRW 2,670.00
-215.00 (-7.45%)
Sep 6, 2026, 3:08 AM KST
GeneOne Life Science Market Cap
GeneOne Life Science has a market cap or net worth of 48.42 billion as of October 12, 2026. It is the 32,822nd most valuable company in the world and the 1,876th biggest in South Korea. Its market cap has decreased by 77.97% in one year.
Market Cap
48.42B
Enterprise Value
76.85B
Revenue
12.37B
Global Rank
Country Rank
#1,876 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 30, 1995, GeneOne Life Science's market cap has increased from 3.40B to 48.42B, an increase of 1,324.11%. That is a compound annual growth rate of 8.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 48.42B | -70.99% |
| Dec 30, 2025 | 166.91B | -1.14% |
| Dec 30, 2024 | 168.84B | -24.04% |
| Dec 28, 2023 | 222.27B | -59.85% |
| Dec 29, 2022 | 553.65B | -55.74% |
| Dec 30, 2021 | 1.25T | 30.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anterogen.Co.,Ltd. | 162.00B |
| Genexine | 132.12B |
| MedPacto | 102.31B |
| Vaxcell-Bio Therapeutics | 101.05B |
| iNtRON Biotechnology | 87.89B |
| Prestige BioPharma | 71.63B |
| Amicogen | 69.47B |
| ENCell | 64.74B |